Skip to main content

Table 1 Demographic data and clinical status of the enrolled patients on the recruitment day

From: Safety and efficacy of autologous non-hematopoietic enriched stem cell nebulization in COVID-19 patients: a randomized clinical trial, Abu Dhabi 2020

Parameter

Group A: Treated with PB-NHESC-C plus standard care (n = 69)

Group B: Control (standard care only) (n = 70)

p-Value

Demographic data

   

Age, years (mean ± SD)

45.93 ± 9.75

44.38 ± 11.09

0.380

Gender, n (%)

   

Total

69 (48.94)

70 (51.06)

 

Masculine

65 (46.10)

64 (46.81)

0.7447

Feminine

4 (2.88)

6 (4.32)

Nationalities

   

Afghanistan

2 (2.90)

1 (1.43)

0.6195

Bangladesh

11 (15.94)

11 (15.71)

1.0000

China PRP

0 (0)

1 (1.43)

1.0000

Egypt

3 (4.35)

3 (4.29)

1.0000

India

22 (31.88)

28 (40.00)

0.2920

Indonesia

1 (1.45)

0 (0)

0.4964

Jordan

0 (0)

1 (1.43)

1.0000

Nepal

5 (7.25)

2 (2.86)

0.2746

Pakistan

10 (14.49)

15 (21.43)

0.3777

Palestine

4 (5.80)

0 (0)

0.0581

Philippines

4 (5.80)

4 (5.71)

1.0000

Somalia

1 (1.45)

0 (0)

0.4964

Sudan

3 (4.35)

0 (0)

0.1196

Syria

1 (1.45)

2 (2.86)

1.0000

UAE

1 (1.45)

1 (1.43)

1.0000

USA

0 (0)

1 (1.43)

1.0000

Unknown

1 (1.45)

0 (0)

0.4964

Health status at recruitment

Body mass index categories, n (%)

Unknown

3 (4.35)

2 (2.86)

0.6806

Normal (healthy weight)

17 (24.64)

29 (41.43)

0.0472a

Overweight

35 (50.74)

19 (27.14)

0.0054b

Obese Class I (moderately obese)

11 (15.94)

13 (18.57)

0.8230

Obese Class II (severely obese)

0 (0)

3 (4.29)

0.2446

Obese Class III (very severely obese)

3 (4.35)

4 (5.71)

1.0000

Moderate COVID- 19, n (%)

Score 3

37 (53.62)

40 (57.14)

0.7342

Score 4

12 (17.39)

6 (8.57)

0.1372

Subtotal

49 (71.01)

46 (65.71)

0.5852

Severe COVID-19, n (%)

Score 5

3 (4.34)

7 (10.00)

0.3255

Score 6

2 (2.89)

1 (1.42)

0.6195

Score 7

15 (21.74)

16 (22.86)

1.0000

Subtotal

20 (28.98)

24 (34.28)

0.5852

Main comorbidities, n (%)

Arterial hypertension

18 (26.09)

19 (27.14)

1.0000

Diabetes mellitus

18 (26.09)

13 (18.57)

0.3142

Cardiovascular disease and dyslipidemia

7 (6.25)

6 (8.57)

0.7792

Chronic smoking and asthma

11 (15.94)

4 (5.71)

0.0603

  1. PB-NHESC-C: peripheral blood non-hematopoietic enriched stem cell cocktail; the p-value for age was determined by a χ2-test; the remaining p-values were determined by the F-exact probability test; a: significant difference; b: highly significant difference